Doctor, my patient has CDI and should continue to receive antibiotics. The (unresolved) risk of recurrent CDI

Recurrence rate ranges from 12% to 40% of all cases of Clostridium difficile infection (CDI) and proposes an exceptional clinical challenge. Conventionally, treatment options of CDI have been limited to regimes of established antibiotics (eg, pulsed/tapered vancomycin) or “improvised” alternative an...

Descripción completa

Detalles Bibliográficos
Autores principales: Castro, Iván, Tasias, Mariona, Calabuig, Eva, Salavert, Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Quimioterapia 2019
Materias:
Update in Nosocomial Infection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755365/
https://www.ncbi.nlm.nih.gov/pubmed/31475811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755365/
https://www.ncbi.nlm.nih.gov/pubmed/31475811

Ejemplares similares